Prime Medicine (NASDAQ: PRME)
$5.36
(-3.8%)
-$0.21
Price as of May 8, 2024, 4:00 p.m. ET
Prime Medicine Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Prime Medicine Company Info
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
2 Magnificent Growth Stocks With Room to Run
These deeply undervalued growth stocks could be big winners for patient shareholders.
George Budwell | Mar 27, 2024
Featured Article
Better Growth Stock: Archer Aviation or Prime Medicine?
Which of these innovation-themed growth stocks is the better buy?
George Budwell | Dec 19, 2023
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
George Budwell | Nov 30, 2023
This gene-editing company could sport a best-in-class platform.
2 Cathie Wood Stocks That Could Be Hidden Gems
George Budwell | Jul 25, 2023
These two biotech stocks could deliver life-altering returns for long-term investors.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.